Clinical trials
Recruiting Urinary Bladder Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Cancer Research UK | 2 |
| Pfizer | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| British Urology Researchers in Surgical Training | 1 |
| Daiichi Sankyo | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 27 |
| Pancreatic Neoplasms | 10 |
| Esophageal Neoplasms | 8 |
| Ovarian Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Head and Neck Neoplasms | 6 |
| Stomach Neoplasms | 6 |
| Carcinoma, Transitional Cell | 5 |
| Kidney Neoplasms | 5 |
| Non-Muscle Invasive Bladder Neoplasms | 5 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.